Literature DB >> 22103481

Embryonal tumor with abundant neuropil and true rosettes: a report of three cases of a rare tumor, with an unusual case showing rhabdomyoblastic and melanocytic differentiation.

Maysa Al-Hussaini1, Najiyah Abuirmeileh, Maisa Swaidan, Usama Al-Jumaily, Haytham Rajjal, Awni Musharbash, Sameh Hashem, Iyad Sultan.   

Abstract

Embryonal tumor with abundant neuropil and true rosettes (ETANTR) is an increasingly recognized entity that belongs to the family of embryonal tumors of the CNS. The authors present three cases of this rare tumor that were encountered at King Hussein Cancer Center, Amman, Jordan. Discussion of the clinicopathological findings is presented along with a recent literature review. Sixteen-, 57- and 30-month-old children presented with tumors located in the pineal gland, the right fronto- parieto-temporal region and the cerebellum, respectively. The findings of hypocellular neuropil as well as the characteristic ependymoblastic rosettes were seen. In addition the third case showed an abnormal combination of patterns including melanocytic and rhabdomyoblastic differentiation. The tumors stained positively for synaptophysin in the neuropil and small cell component, while the ependymoblastic rosettes stained for vimentin only. Epithelial membrane antigen and CD99 were negative in all components. One of the cases showed tetraploidy of chromosome 2. All cases exhibited an aggressive course. This is a rare and recently recognized tumor with dismal outcome, and reporting of additional new cases should help in gaining more knowledge about it.
© 2011 Japanese Society of Neuropathology.

Entities:  

Mesh:

Year:  2011        PMID: 22103481     DOI: 10.1111/j.1440-1789.2011.01213.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  6 in total

1.  CT and Multimodal MR Imaging Features of Embryonal Tumors with Multilayered Rosettes in Children.

Authors:  V Dangouloff-Ros; A Tauziède-Espariat; C-J Roux; R Levy; D Grévent; F Brunelle; A Gareton; S Puget; K Beccaria; T Blauwblomme; J Grill; C Dufour; P Varlet; N Boddaert
Journal:  AJNR Am J Neuroradiol       Date:  2019-03-07       Impact factor: 3.825

Review 2.  Evaluation of the good tumor response of embryonal tumor with abundant neuropil and true rosettes (ETANTR).

Authors:  Petra Mozes; Péter Hauser; Tibor Hortobágyi; Gábor Benyó; István Peták; Miklós Garami; Adrienne Cserháti; Katalin Bartyik; László Bognár; Zoltán Nagy; Eszter Turányi; Katalin Hideghéty
Journal:  J Neurooncol       Date:  2015-09-15       Impact factor: 4.130

3.  Medulloepithelioma with heterologous osteoid component: a case report and review of literature.

Authors:  Yanal Omari; Ahmad A Karkash; Razan A Mansour; Nisreen Amayiri; Maisa Swaidan; Maysa Al-Hussaini
Journal:  Childs Nerv Syst       Date:  2019-01-08       Impact factor: 1.475

4.  Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity.

Authors:  Andrey Korshunov; Dominik Sturm; Marina Ryzhova; Volker Hovestadt; Marco Gessi; David T W Jones; Marc Remke; Paul Northcott; Arie Perry; Daniel Picard; Marc Rosenblum; Manila Antonelli; Eleonora Aronica; Ulrich Schüller; Martin Hasselblatt; Adelheid Woehrer; Olga Zheludkova; Ella Kumirova; Stephanie Puget; Michael D Taylor; Felice Giangaspero; V Peter Collins; Andreas von Deimling; Peter Lichter; Annie Huang; Torsten Pietsch; Stefan M Pfister; Marcel Kool
Journal:  Acta Neuropathol       Date:  2013-12-14       Impact factor: 17.088

5.  Radiation for ETMR: Literature review and case series of patients treated with proton therapy.

Authors:  Sergio Jaramillo; David R Grosshans; Nancy Philip; Ali Varan; Canan Akyüz; Mary Frances McAleer; Anita Mahajan; Susan L McGovern
Journal:  Clin Transl Radiat Oncol       Date:  2018-11-07

Review 6.  ETMR: a tumor entity in its infancy.

Authors:  Sander Lambo; Katja von Hoff; Andrey Korshunov; Stefan M Pfister; Marcel Kool
Journal:  Acta Neuropathol       Date:  2020-06-29       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.